Two Filtration Futures for Water Dispense

On May 18, 2026 the US Environmental Protection Agency issued two simultaneous proposed rules that, taken together, formally bisect the US PFAS regulatory regime. The first upholds the 4.0 parts-per-trillion Maximum Contaminant Levels for PFOA and PFOS set under the April 2024 NPDWR — but introduces a federal exemption framework giving drinking water systems an additional two years (to 2031) to comply. The second proposes to rescind the MCLs entirely for PFHxS, PFNA, GenX (HFPO-DA) and the Hazard Index mixture rule for PFBS — on procedural grounds that the Biden-era rulemaking did not follow the Safe Drinking Water Act's procedural requirements. A 60-day comment window opened the same day. A virtual public hearing is set for July 7, 2026.

Two days earlier, the European Chemicals Agency entered the final week of its universal PFAS restriction consultation (closes May 25, with the Socio-Economic Analysis Committee final opinion expected by end of 2026). Eight days earlier — May 11, 2026 — EU Directive 2026/805 entered force, adding 25 PFAS including trifluoroacetic acid (TFA) to the regulated list for surface and groundwater. The UK's draft Persistent Organic Pollutants amendment covers 47 compounds.

By the close of this week the US and EU regulatory regimes for the chemistry that sits inside every commercial water dispense filter are pointed in formally opposite directions — and water dispense operators on either side of the Atlantic now face structurally different cost-of-credentials curves.

What the EPA actually did — and didn't do

The EPA's first rule keeps the headline limits intact. PFOA and PFOS stay at 4 ppt, no rollback on the numbers most carbon-block filtration was already engineered around. The federal exemption framework adds optionality: drinking water systems in states without primacy for those MCLs can request a two-year deferral, extending compliance from 2029 to 2031. That is a procurement decompression for utilities, not a reversal.

The second rule is more structural. By proposing to rescind the MCLs for PFHxS, PFNA, GenX and the PFBS Hazard Index — and using a procedural "unlawful promulgation" rationale rather than a scientific one — the EPA leaves the door open to re-promulgate later but removes federal enforceability now. The long tail of regulated PFAS compounds — exactly the compounds where carbon block fails and only reverse osmosis or ion exchange holds — drops off the federal compliance scorecard. State-level PFAS rules (New Jersey, California, New York, Michigan, Massachusetts) remain — but the federal floor for the broader compound set is being removed.

Why this matters more in Europe than in America

In Europe the trajectory is the opposite. EU Directive 2026/805 brought TFA — the most operationally decisive PFAS for water dispense because it is in 94% of EU tap and 63% of EU bottled-water samples — into the regulated list as of May 11. ECHA's universal restriction proposal covers more than 10,000 PFAS substances across 231 industrial use categories, including water treatment components. The UK's 47-compound POPs scope sits structurally tighter than even the EU baseline.

For European water dispense operators that means three credential dimensions widen simultaneously: scope (which compounds), level (how strict), and traceability (which standard certifies the equipment). BWT UK's NSF/ANSI 58 RO platform and Borg & Overström's T-series with ion exchange are already positioned for the post-May-11 EU compound list; carbon-block-only POU is not. Brita's CLARITY Protect launch on its commercial Vivreau line (covered in our May 18 piece) reads as the OEM-led baseline shift driven by exactly this regulatory direction.

For US-exposed operators: less filtration pressure, more bottle pressure

For US water dispense players — Primo Brands, Culligan/Quench, Bevi, Waterlogic Americas — the federal calculus shifts. PFOA and PFOS still need to be addressed in source water, but most office POU/ITS units with NSF/ANSI 53-certified carbon block already handle those two. The four PFAS being rescinded were the compounds that would have forced procurement upgrades to RO, ion exchange or multi-stage POU — and that procurement push just lost its federal scaffolding.

The pressure point for US dispense moves back to bottle exposure (BWD plastic, BPA, single-use packaging) and state-level patchwork rather than federal filtration compliance. For sub-Culligan US operators, the federal regulatory urgency for upgrading installed base just decelerated, but the state-level urgency in NJ/CA/MI did not.

For EU-exposed operators: the credentials moat just deepened

European mid-market operators face the opposite curve. Every tender from Q3 2026 onwards is going to specify against an EU compound list that just grew, an ECHA SEAC opinion that is coming in months, and a UK 47-compound scope that already exists — at the same time their US peers are being released from broader federal scope.

What that does to capital allocation: PE buyers underwriting cross-Atlantic platform plays now have to model two filtration cost curves, not one. The European mid-market filtration-cred play (BWT, Borg & Overström, Aquablu, Dripl, Brita Vivreau and the operators distributing them) becomes a credential-moat asset; the US-only carbon-block fleet becomes a less defensible asset on the same comparable revenue.

What to watch in the next 60 days

Three events will set the post-divergence baseline. ECHA universal restriction consultation closes May 25. EPA public hearing on both proposed rules runs July 7. ECHA SEAC final opinion is expected by end of 2026. Operators with multi-stage POU and RO certifications should be locking in tender language and product-page claims now — before the credentials shortage becomes the lead variable in Q3 procurement cycles.